Brief: Black Diamond Therapeutics Reports First Quarter 2023 Financial Results

Black Diamond Therapeutics

09/05/2023 13:35

May 9 (Reuters) - Black Diamond Therapeutics Inc
 BDTX.O :
    * BLACK DIAMOND THERAPEUTICS REPORTS FIRST QUARTER 2023
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
    * BLACK DIAMOND THERAPEUTICS - CASH, CASH EQUIVALENTS, AND
INVESTMENTS OF $103.4 MILLION AS OF MARCH 31; SUFFICIENT TO FUND
OPERATIONS INTO Q3 OF 2024
    * BLACK DIAMOND THERAPEUTICS INC - ANNOUNCES NOMINATION OF
DEVELOPMENT CANDIDATE, BDTX-4876, FOR FGFR 2/3 SELECTIVE
INHIBITOR PROGRAM
    * BLACK DIAMOND THERAPEUTICS INC - TO EVALUATE STRATEGIC
ALTERNATIVES FOR FGFR 2/3 SELECTIVE INHIBITOR PROGRAM
    * BLACK DIAMOND THERAPEUTICS INC - QTRLY LOSS PER SHARE
$0.57
    * BLACK DIAMOND THERAPEUTICS - CONTINUES TO LEVERAGE MAP
DRUG
DISCOVERY ENGINE TO ADVANCE DISCOVERY-STAGE PIPELINE

Source text for Eikon:  ID:nGNX282VwN 
Further company coverage:  BDTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))